Diclofenac Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

72 API Suppliers, 21 USDMF, 16 CEP/COS, 13 JDMF, 7 EU WC, 20 KDMF, 27 NDC API, 42 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

469 Dossiers, 99 FDA Orange Book, 121 Europe, 34 Canada, 60 South Africa, 155 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 2%, TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG, TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG, SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1%, SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;TOPICAL - 2%
TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG
TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG
SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TOPICAL - 1%
SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 48 BASF, 38 Kerry, 24 Roquette, 18 Corel Pharma Chem, 16 Microlex e.U, 15 Seppic, 15 Actylis, 14 Ideal Cures Pvt Ltd, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 Nanjing Well Pharmaceutical, 11 SPI Pharma, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 7 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 DKSH, 4 Alcedo Pharmachem, 4 Ingredion Pharma Solutions, 4 Ulanqab Kema New Material, 3 Kima Chemical, 3 Doshion Polyscience, 3 Aeon Procare, 3 Finar, 2 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Evonik, 2 Shandong Focus Biotechnology Co., Ltd, 2 Lubrizol Life Science Health, 2 Nanjing Bold Chemical, 2 Seqens, 2 Nomisma Healthcare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Shanghai Welltone Material Technology Co., Ltd, 1 BioSpectra, 1 Qualicaps, 1 Rochem International Inc, 1 Pfanstiehl, 1 Huzhou Sunflower Pharmaceutical, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 72 Coating Systems & Additives, 50 Controlled & Modified Release, 46 Solubilizers, 45 Direct Compression, 42 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 34 Granulation, 34 Topical, 25 Parenteral, 24 Lubricants & Glidants, 22 Film Formers & Plasticizers, 20 Taste Masking, 18 Co-Processed Excipients, 15 Emulsifying Agents, 10 Chewable & Orodispersible Aids, 9 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents